Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Fulcrum Therapeutics (FULC)
NASDAQ:FULC
Fulcrum Therapeutics (FULC) Stock Price & Analysis
189 Followers
FULC Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$3.07 - $24.79
Previous Close$3.14
Volume833.19K
Average Volume (3M)1.33M
Market Cap
$193.92M
Enterprise Value$4.43M
Total Cash (Recent Filing)$202.92M
Total Debt (Recent Filing)$13.42M
Price to Earnings (P/E)-1.3
Beta1.79
Next Earnings
May 17, 2023EPS Estimate
-$0.46Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.49
Shares Outstanding61,666,789
10 Day Avg. Volume726,072
30 Day Avg. Volume1,330,705
Standard Deviation0.59
R-Squared0.04
Alpha0.08
Financial Highlights & Ratios
Price to Book (P/B)3.39
Price to Sales (P/S)132.66
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-9.50
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.70
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-0.04
Forecast
1Y Price Target
$10.22Price Target Upside224.44% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering9
Fulcrum Therapeutics News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
FULC FAQ
What was Fulcrum Therapeutics’s price range in the past 12 months?
Fulcrum Therapeutics lowest stock price was $3.06 and its highest was $24.79 in the past 12 months.
What is Fulcrum Therapeutics’s market cap?
Currently, no data Available
When is Fulcrum Therapeutics’s upcoming earnings report date?
Fulcrum Therapeutics’s upcoming earnings report date is May 17, 2023 which is in 53 days.
How were Fulcrum Therapeutics’s earnings last quarter?
Fulcrum Therapeutics released its earnings results on Mar 09, 2023. The company reported -$0.5 earnings per share for the quarter, missing the consensus estimate of -$0.49 by -$0.01.
Is Fulcrum Therapeutics overvalued?
According to Wall Street analysts Fulcrum Therapeutics’s price is currently Undervalued.
Does Fulcrum Therapeutics pay dividends?
Fulcrum Therapeutics does not currently pay dividends.
What is Fulcrum Therapeutics’s EPS estimate?
Fulcrum Therapeutics’s EPS estimate is -$0.46.
How many shares outstanding does Fulcrum Therapeutics have?
Fulcrum Therapeutics has 61,758,995 shares outstanding.
What happened to Fulcrum Therapeutics’s price movement after its last earnings report?
Fulcrum Therapeutics reported an EPS of -$0.5 in its last earnings report, missing expectations of -$0.49. Following the earnings report the stock price went down -23.003%.
Which hedge fund is a major shareholder of Fulcrum Therapeutics?
Among the largest hedge funds holding Fulcrum Therapeutics’s share is RA Capital Management. It holds Fulcrum Therapeutics’s shares valued at 69M.
---
Fulcrum Therapeutics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$10.22 (224.44% Upside)
$10.22 (224.44% Upside)
Hedge Fund Trend
Increased
By 2.3M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $26.3M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.0%
Last 30 Days ▼ 0.9%
Last 30 Days ▼ 0.9%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-82.98%
12-Months-Change
Fundamentals
Return on Equity
-53.53%
Trailing 12-Months
Asset Growth
-3.54%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Fulcrum Therapeutics
Fulcrum Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It develops new medicines and focuses on unlocking gene control mechanisms to develop small molecule therapies. Its product candidate includes Losmapimod and FTX-HbF. The company was founded by Michael R. Green, Danny Reinberg, Rudolf Jaenisch, Jeannie T. Lee, and Bradley E. Bernstein on August 18, 2015 and is headquartered in Cambridge, MA.
---
Top 5 ETFs holding FULC
Fidelity Nasdaq Composite Index ETF
$454.46K
Dimensional U.S. Equity ETF
$30.22K
Up to five ETFs with an Outperform Smart Score that hold FULC. The ETFs are listed according to market value of FULC within the ETF
---
---